{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:21:49Z","timestamp":1765545709643},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T00:00:00Z","timestamp":1310083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s11739-011-0647-y","type":"journal-article","created":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T10:19:07Z","timestamp":1310033947000},"page":"191-203","source":"Crossref","is-referenced-by-count":38,"title":["Cardiac amyloidosis: the heart of the matter"],"prefix":"10.1007","volume":"8","author":[{"given":"Federico","family":"Perfetto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Bergesio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Ciuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Porciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Padeletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Moggi Pignone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,8]]},"reference":[{"key":"647_CR1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","volume":"91","author":"SW Dubrey","year":"1998","unstructured":"Dubrey SW, Cha K, Anderson J et al (1998) The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 91:141\u2013157","journal-title":"QJM"},{"key":"647_CR2","first-page":"45","volume":"32","author":"RA Kyle","year":"1995","unstructured":"Kyle RA, Gertz MA (1995) Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 32:45\u201359","journal-title":"Semin Hematol"},{"key":"647_CR3","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","volume":"79","author":"RA Kyle","year":"1992","unstructured":"Kyle RA, Linos A, Beard CM et al (1992) Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood 79:1817\u20131822","journal-title":"Blood"},{"key":"647_CR4","unstructured":"Hazembergh BPC, Van Rijswisk MH (2000) Aspects cliniques de l\u2019amylose AA. In: Grateau G, Benson MD, Delpech M (eds) Les Amyloses. M\u00e9dicine-Sciences Flammarion, Paris, pp 377\u2013427"},{"key":"647_CR5","first-page":"1074","volume":"26","author":"N Magy-Bertrand","year":"2008","unstructured":"Magy-Bertrand N, Dupond JL, Mauny F, Dupond AS, Duchene F, Gil H, Kantelip B, The CRISAP Members (2008) Incidence of amyloidosis over 3\u00a0years: the AMYPRO study. Clin Exp Rheum 26:1074\u20131078","journal-title":"Clin Exp Rheum"},{"key":"647_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbapap.2005.08.014","volume":"1753","author":"L Obici","year":"2005","unstructured":"Obici L, Perfetti V, Palladini G, Moratti R, Merlini G (2005) Clinical aspects of systemic amyloid diseases. Biochem Biophys Acta 1753:11\u201322","journal-title":"Biochem Biophys Acta"},{"key":"647_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.md.0000091183.93122.c7","volume":"82","author":"MA Park","year":"2003","unstructured":"Park MA, Mueller PS, Kyle RA et al (2003) Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine 82:291\u2013298","journal-title":"Medicine"},{"key":"647_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000051681","volume":"202","author":"FO Nestle","year":"2001","unstructured":"Nestle FO, Burg G (2001) Bilateral carpal tunnel syndrome as a clue for the diagnosis of systemic amyloidosis. Dermatology 202:353\u2013355","journal-title":"Dermatology"},{"issue":"12","key":"647_CR9","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1517\/14656566.9.12.2117","volume":"9","author":"T Pettersson","year":"2008","unstructured":"Pettersson T, Konttinen YT, Maury CPJ (2008) Treatment strategies for amyloid A amyloidosis. Expert Opin Pharmacother 9(12):2117\u20132128","journal-title":"Expert Opin Pharmacother"},{"key":"647_CR10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00041552-200211000-00013","volume":"11","author":"PN Hawkins","year":"2002","unstructured":"Hawkins PN (2002) Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr Opin Nephrol Hypertens 11:649\u2013655","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"647_CR11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005792-199107000-00002","volume":"70","author":"MA Gertz","year":"1991","unstructured":"Gertz MA, Kyle RA (1991) Secondary systemic amyloidosis: response and survival in 64 patients. Medicine 70:246\u2013256","journal-title":"Medicine"},{"key":"647_CR12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20821","volume":"36","author":"MD Benson","year":"2007","unstructured":"Benson MD, Kincaid JC (2007) The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 36:411\u2013423","journal-title":"Muscle Nerve"},{"key":"647_CR13","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0002-9343(83)90443-6","volume":"75","author":"GG Cornwell III","year":"1983","unstructured":"Cornwell GG III, Murdoch WL, Kyle RA, Westermark P, Pitkanen P (1983) Frequency and distribution of senile cardiovascular amyloid: a clinicopathologic correlation. Am J Med 75:618\u2013623","journal-title":"Am J Med"},{"key":"647_CR14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.amjcard.2004.10.028","volume":"95","author":"B Murtagh","year":"2005","unstructured":"Murtagh B, Hammill SC, Gertz MA et al (2005) Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol 95:535\u2013537","journal-title":"Am J Cardiol"},{"key":"647_CR15","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.107.697763","volume":"116","author":"D Feng","year":"2007","unstructured":"Feng D, Edwards WD, Krishnaswamy JKO et al (2007) Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation 116:2420\u20132426","journal-title":"Circulation"},{"key":"647_CR16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9343(00)00471-X","volume":"109","author":"PS Mueller","year":"2000","unstructured":"Mueller PS, Edwards WD, Gertz MA (2000) Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis. Am J Med 109:181\u2013188","journal-title":"Am J Med"},{"key":"647_CR17","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0002-9149(97)00653-X","volume":"80","author":"B Chamarthi","year":"1997","unstructured":"Chamarthi B, Dubrey SW, Cha K et al (1997) Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis. Am J Cardiol 80:1242\u20131245","journal-title":"Am J Cardiol"},{"key":"647_CR18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0735-1097(84)80436-2","volume":"3","author":"RH Falk","year":"1984","unstructured":"Falk RH, Rubinow A, Cohen AS (1984) Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities. J Am Coll Cardiol 3:107\u2013113","journal-title":"J Am Coll Cardiol"},{"key":"647_CR19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0002-9149(87)90948-9","volume":"59","author":"RH Falk","year":"1987","unstructured":"Falk RH, Plehn J, Deering T et al (1987) Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol 59:418\u2013422","journal-title":"Am J Cardiol"},{"key":"647_CR20","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0735-1097(90)90545-Z","volume":"16","author":"AL Klein","year":"1990","unstructured":"Klein AL, Hatle LK, Taliercio CP et al (1990) Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 16:1135\u20131141","journal-title":"J Am Coll Cardiol"},{"key":"647_CR21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jacc.2003.08.043","volume":"43","author":"JE Rahman","year":"2004","unstructured":"Rahman JE, Helou EF, Gelzer-Bell R et al (2004) Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 43:410\u2013415","journal-title":"J Am Coll Cardiol"},{"key":"647_CR22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9149(83)80139-8","volume":"51","author":"AK Bhandari","year":"1983","unstructured":"Bhandari AK, Nanda NC (1983) Myocardial texture characterization by two-dimensional echocardiography. Am J Cardiol 51:817\u2013825","journal-title":"Am J Cardiol"},{"key":"647_CR23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0002-9149(92)90250-3","volume":"69","author":"M Simons","year":"1992","unstructured":"Simons M, Isner JM (1992) Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis. Am J Cardiol 69:425\u2013427","journal-title":"Am J Cardiol"},{"key":"647_CR24","first-page":"391","volume":"21","author":"M Hongo","year":"1991","unstructured":"Hongo M, Kono J, Yamada H et al (1991) Doppler echocardiographic assessments of left ventricular diastolic filling in patients with amyloid heart disease. J Cardiol 21:391\u2013401","journal-title":"J Cardiol"},{"key":"647_CR25","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0002-9149(02)02277-4","volume":"89","author":"J Koyama","year":"2002","unstructured":"Koyama J, Ray-Sequin PA, Davidoff R et al (2002) Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol 89:1067\u20131071","journal-title":"Am J Cardiol"},{"key":"647_CR26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13506120902879681","volume":"16","author":"MC Porciani","year":"2009","unstructured":"Porciani MC, Lilli A, Perfetto F et al (2009) Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis. Amyloid 16:63\u201370","journal-title":"Amyloid"},{"key":"647_CR27","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/01.CIR.0000068313.67758.4F","volume":"107","author":"J Koyama","year":"2003","unstructured":"Koyama J, Ray-Sequin PA, Falk RH (2003) Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107:2446\u20132452","journal-title":"Circulation"},{"key":"647_CR28","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1540-8175.2010.01199.x","volume":"27","author":"MC Porciani","year":"2010","unstructured":"Porciani MC, Cappelli F, Perfetto F et al (2010) Rotational mechanics of the left ventricle in AL amyloidosis. Echocardiography 27:1061\u20131068","journal-title":"Echocardiography"},{"key":"647_CR29","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1161\/CIRCULATIONAHA.105.596502","volume":"113","author":"Y Notomi","year":"2006","unstructured":"Notomi Y, Martin-Miklovic MG, Oryszak SJ, Shiota T, Deserranno D, Popovic ZB, Garcia MJ, Greenberg NL, Thomas JD (2006) Enhanced ventricular untwisting during exercise: a mechanistic manifestation of elastic recoil described by Doppler tissue imaging. Circulation 113:2524\u20132533","journal-title":"Circulation"},{"key":"647_CR30","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","volume":"120","author":"C Rapezzi","year":"2009","unstructured":"Rapezzi C, Merlini G, Quarta CC et al (2009) Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 120:1203\u20131212","journal-title":"Circulation"},{"key":"647_CR31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","volume":"111","author":"AM Maceira","year":"2005","unstructured":"Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E et al (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111:186\u2013193","journal-title":"Circulation"},{"key":"647_CR32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/hrt.2005.061911","volume":"92","author":"E Perugini","year":"2006","unstructured":"Perugini E, Rapezzi C, Piva T et al (2006) Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 92:343\u2013349","journal-title":"Heart"},{"key":"647_CR33","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","volume":"46","author":"E Perugini","year":"2005","unstructured":"Perugini E, Guidalotti PL, Salvi F et al (2005) Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 46:1076\u20131084","journal-title":"J Am Coll Cardiol"},{"key":"647_CR34","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(03)13396-X","volume":"361","author":"A Dispenzieri","year":"2003","unstructured":"Dispenzieri A, Kyle RA, Gertz MA et al (2003) Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 361:1787\u20131789","journal-title":"Lancet"},{"issue":"18","key":"647_CR35","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","volume":"22","author":"A Dispenzieri","year":"2004","unstructured":"Dispenzieri A, Gertz M, Kyle R et al (2004) Serum cardiac troponins and N-terminal probrain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol 22(18):3751\u20133757","journal-title":"J Clin Oncol"},{"key":"647_CR36","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1182\/blood-2005-11-4385","volume":"107","author":"G Palladini","year":"2006","unstructured":"Palladini G, Lavatelli F, Russo P et al (2006) Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL. Blood 107:3854\u20133858","journal-title":"Blood"},{"key":"647_CR37","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1182\/blood-2010-02-267708","volume":"116","author":"AV Kristen","year":"2010","unstructured":"Kristen AV, Giannitsis E, Lehrke S, Hegenbart U, Konstandin M et al (2010) Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin-T assay. Blood 116:2455\u20132461","journal-title":"Blood"},{"key":"647_CR38","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1182\/blood-2010-05-286567","volume":"116","author":"G Palladini","year":"2010","unstructured":"Palladini G, Barassi A, Klersy C, Pacciolla R, Milani P et al (2010) The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis. Blood 116:3426\u20133430","journal-title":"Blood"},{"key":"647_CR39","unstructured":"Gertz MA, Merlini G (2010) Definition of organ involvement and response to treatment in AL amyloidosis: un updated consensus opinion (abstract). Amyloid 17(s1):48"},{"key":"647_CR40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/anr.1780320114","volume":"32","author":"MA Duston","year":"1989","unstructured":"Duston MA, Skinner M, Meenan RF, Cohen AS (1989) Sensitivity, specificity, and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis. Arthritis Rheum 32:82\u201385","journal-title":"Arthritis Rheum"},{"key":"647_CR41","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1074\/mcp.M700545-MCP200","volume":"7","author":"F Lavatelli","year":"2008","unstructured":"Lavatelli F, Perlman DH, Spencer B et al (2008) Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol Cell Proteomics 7:1570\u20131583","journal-title":"Mol Cell Proteomics"},{"key":"647_CR42","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","volume":"337","author":"RH Falk","year":"1997","unstructured":"Falk RH, Comenzo RL, Skinner M (1997) The systemic amyloidoses. N Engl J Med 337:898\u2013909","journal-title":"N Engl J Med"},{"key":"647_CR43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0735-1097(85)80475-7","volume":"6","author":"L Cueto-Garcia","year":"1985","unstructured":"Cueto-Garcia L, Reeder GS, Kyle RA et al (1985) Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 6:737\u2013743","journal-title":"J Am Coll Cardiol"},{"key":"647_CR44","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/01.CIR.83.3.808","volume":"83","author":"AL Klein","year":"1991","unstructured":"Klein AL, Hatle LK, Taliercio CP et al (1991) Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. Circulation 83:808\u2013816","journal-title":"Circulation"},{"key":"647_CR45","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejheart.2007.05.006","volume":"9","author":"S Ghio","year":"2007","unstructured":"Ghio S, Perlini S, Palladini G et al (2007) Importance of the echocardiographic evaluation of right ventricular function in patients with AL amyloidosis. Eur J Heart Fail 9:808\u2013813","journal-title":"Eur J Heart Fail"},{"key":"647_CR46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jcmg.2009.11.013","volume":"3","author":"J Koyama","year":"2010","unstructured":"Koyama J, Falk RH (2010) Prognostic significance of strain Doppler imaging in light-chain amyloidosis. J Am Coll Cardiol Imag 3:333\u2013342","journal-title":"J Am Coll Cardiol Imag"},{"key":"647_CR47","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.echo.2010.03.027","volume":"23","author":"D Bellavia","year":"2010","unstructured":"Bellavia D, Pellikka PA, Al-Zahrani GB et al (2010) Independent predictors of survival in primary systemic (AL) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study. J Am Soc Echocardiogr 23:643\u2013652","journal-title":"J Am Soc Echocardiogr"},{"key":"647_CR48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","volume":"358","author":"JD Gillmore","year":"2001","unstructured":"Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358:24\u201329","journal-title":"Lancet"},{"key":"647_CR49","first-page":"941","volume":"2","author":"F Bergesio","year":"2008","unstructured":"Bergesio F, Ciciani AM, Manganaro M, Palladini G, Santostefano M, Brugnano R (2008) Renal involvement in systemic amyloidosis An Italian collaborative study on survival and renal outcome Nephrol. Dial Transplant 2:941\u2013951","journal-title":"Dial Transplant"},{"key":"647_CR50","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","volume":"356","author":"HJ Lachmann","year":"2007","unstructured":"Lachmann HJ, Goodman HJB, Gilbertson JA et al (2007) Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356:2361\u20132371","journal-title":"N Engl J Med"},{"key":"647_CR51","doi-asserted-by":"crossref","unstructured":"Rapezzi, C. Perugini E, Salvi F et al. (2006) Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies? Amyloid 13:143\u2013153","DOI":"10.1080\/13506120600877136"},{"key":"647_CR52","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nrcardio.2010.67","volume":"7","author":"C Rapezzi","year":"2010","unstructured":"Rapezzi C, Quarta CC, L Riva et al (2010) Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol 7:398\u2013408","journal-title":"Nat Rev Cardiol"},{"key":"647_CR53","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archinte.165.12.1425","volume":"165","author":"B Ng","year":"2005","unstructured":"Ng B, Connors LH, Davidoff R, Skinner M, Falk RH (2005) Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 165:1425\u20131429","journal-title":"Arch Intern Med"},{"key":"647_CR54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/hrt.78.1.74","volume":"78","author":"SW Dubrey","year":"1997","unstructured":"Dubrey SW, Cha K, Skinner M, LaValley M, Falk RH (1997) Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart 78:74\u201382","journal-title":"Heart"},{"key":"647_CR55","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.104.2.618","volume":"104","author":"A Pollak","year":"1993","unstructured":"Pollak A, Falk RH (1993) Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis. Chest 104:618\u2013620","journal-title":"Chest"},{"key":"647_CR56","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.63.6.1285","volume":"63","author":"A Rubinow","year":"1981","unstructured":"Rubinow A, Skinner M, Cohen AS (1981) Digoxin sensitivity in amyloid cardiomyopathy. Circulation 63:1285\u20131288","journal-title":"Circulation"},{"key":"647_CR57","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/hrt.74.5.541","volume":"74","author":"S Dubrey","year":"1995","unstructured":"Dubrey S, Pollak A, Skinner M, Falk RH (1995) Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br Heart J 74:541\u2013544","journal-title":"Br Heart J"},{"key":"647_CR58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.hrthm.2007.10.016","volume":"5","author":"AV Kristen","year":"2008","unstructured":"Kristen AV, Dengler TJ, Hegenbart U, Schonland SO, Goldschmidt H et al (2008) Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death heart rhythm. Heart Rhythm 5:235\u2013240","journal-title":"Heart Rhythm"},{"key":"647_CR59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-140-2-200401200-00008","volume":"140","author":"M Skinner","year":"2004","unstructured":"Skinner M, Sanchorawala V, Seldin DC et al (2004) High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 140:85\u201393","journal-title":"Ann Intern Med"},{"key":"647_CR60","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1704346","volume":"33","author":"V Sanchorawala","year":"2004","unstructured":"Sanchorawala V, Wright DG, Seldin DC et al (2004) High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial. Bone Marrow Transplant 33:381\u2013388","journal-title":"Bone Marrow Transplant"},{"key":"647_CR61","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1182\/blood-2003-08-2788","volume":"103","author":"G Palladini","year":"2004","unstructured":"Palladini G, Perfetti V, L Obici et al (2004) The association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis ineligible for stem cell transplantation. Blood 103:2936\u20132938","journal-title":"Blood"},{"key":"647_CR62","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1182\/blood-2004-08-3231","volume":"105","author":"G Palladini","year":"2005","unstructured":"Palladini G, Perfetti V, Perlini S et al (2005) The combination of thalidomide and intermediate dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL). Blood 105:2949\u20132951","journal-title":"Blood"},{"key":"647_CR63","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1182\/blood-2006-07-030544","volume":"109","author":"V Sanchorawala","year":"2007","unstructured":"Sanchorawala V, Finn KT, Fennessey S et al (2007) Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial. Blood 109:492\u2013496","journal-title":"Blood"},{"key":"647_CR64","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1182\/blood-2010-07-294405","volume":"116","author":"P Moreau","year":"2010","unstructured":"Moreau P, Jaccard A, Benboubker L et al (2010) Lenalidomide in combination with melphalan and dexamethasone in patients with newly-diagnosed AL amyloidosis: a multicenter phase 1\/2 dose escalation study. Blood 116:4777\u20134782","journal-title":"Blood"},{"key":"647_CR65","doi-asserted-by":"crossref","unstructured":"Kumar S, Hayman SR, Buadi F et al. (2009) A phase II trial of lenalidomide, cyclophosphamide and dexamethasone (RCD) in patients with light chain amyloidosis. Blood (ASH Annual Meeting Abstracts) 114 (abstr 3853)","DOI":"10.1182\/blood.V114.22.3853.3853"},{"key":"647_CR66","unstructured":"Dispenzieri A, Gertz MA, Hayman SR et al (2010) Pomalidomide and dexamethasone for previously treated AL: a phase 2 study. Amyloid 17(s1):87"},{"key":"647_CR67","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1182\/blood-2009-02-203398","volume":"114","author":"D Reece","year":"2009","unstructured":"Reece D, Sanchorawala V, Hegenbart U et al (2009) Weekly and twice-weekly bortezomib in patients with systemic AL-amyloidosis: results of a phase 1 dose escalation study. Blood 114:1489\u20131497","journal-title":"Blood"},{"key":"647_CR68","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3324\/haematol.11627","volume":"93","author":"AD Wechalekar","year":"2008","unstructured":"Wechalekar AD, Lachmann HJ, Offer M, Hawkins PN, Gillmore JD (2008) Efficacy of bortezomib in systemic AL amyloidosis with relapsed\/refractory clonal disease. Haematologica 93:295\u2013298","journal-title":"Haematologica"},{"key":"647_CR69","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3324\/haematol.11325","volume":"92","author":"E Kastritis","year":"2007","unstructured":"Kastritis E, Anagnostopoulos A, Roussou M et al (2007) Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone. Haematologica 92:1351\u20131358","journal-title":"Haematologica"},{"key":"647_CR70","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1200\/JCO.2009.23.8220","volume":"28","author":"E Kastritis","year":"2010","unstructured":"Kastritis E, Wechalekar AD, Dimopoulos MA et al (2010) Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis. J Clin Oncol 28:1031\u20131037","journal-title":"J Clin Oncol"},{"key":"647_CR71","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/rheumatology\/keh357","volume":"43","author":"E Drewe","year":"2004","unstructured":"Drewe E, Huggins ML, Morgan AG, Cassidy MJ, Powell RJ (2004) Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology 43:1405\u20131408","journal-title":"Rheumatology"},{"key":"647_CR72","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/labinvest.3700059","volume":"84","author":"SR Miller","year":"2004","unstructured":"Miller SR, Sekijima Y, Kelly JW (2004) Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants. Lab Invest 84:545\u2013552","journal-title":"Lab Invest"},{"key":"647_CR73","unstructured":"Coelho T, Maia L, Martin da Silva A (2010) Tafamidis (Fx-1006A): a first-in-class disease-modifying therapy for transthyretin familial amyloid. Amyloid 17(S1):75\u201376"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-011-0647-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-011-0647-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-011-0647-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T05:37:27Z","timestamp":1592717847000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-011-0647-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,8]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["647"],"URL":"https:\/\/doi.org\/10.1007\/s11739-011-0647-y","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,8]]}}}